|
Home : What is Nephrogenic Systemic Fibrosis (NSF)? What is Nephrogenic Systemic Fibrosis (NSF)?
Nephrogenic Systemic Fibrosis is a recently discovered disease that occurs in kidney patients. A strong correlation has also been found between NFS and gadolinium containing MRI contrast dyes. This disease affects the skin and results in tightening and swelling, and may cause contractures due to the thickening of the skin, limiting movement of the joints. A number of treatments have been tried and are being investigated, though none have proved consistently successful.
Who is at Risk of Contracting Nephrogenic Systemic Fibrosis?So far, Nephrogenic Systemic Fibrosis has only been found in patients with kidney disease. Men, women, the old, and the young are all affected by this disease. Other factors that may be associated with Nephrogenic Systemic Fibrosis are coagulation abnormalities, deep vein thrombosis, recent surgery, or the failure of a transplanted kidney. Although the FDA has recently issued a warning about the possible link between gadolinium containing contrast dyes, there is as yet no proven cause and effect factor between these two, but strong correlations are shown.Symptoms of Nephrogenic Systemic FibrosisNephrogenic Systemic Fibrosis is a disease that develops over days or weeks and involves swelling, tightening, and thickening of the skin, which may also lead to contractures and make the movement of joints difficult, thus making it impossible for the patient to walk. The skin may also develop red or darkened patches, plaques, or papules and the patient may experience burning, itching, or severe pain in the area. The skin also develops an orange-peel texture and may feel woody.Treatment of Nephrogenic Systemic FibrosisA number of treatment options have been tried, though none have yet proved consistently effective. These treatments include oral steroids, topical Dovonex, extracorporeal photopheresis, plasmapheresis, Cytoxan, Thalidomide, ultraviolet therapy, physical therapy, Pentoxifylline, high dose intravenous Ig therapy, and renal transplantation. In general though, improving renal functioning does appear to slow or arrest the development of Nephrogenic Systemic Fibrosis.Find a Gadolinium & Nephrogenic System Fibrosis (NSF) Lawyer Now
This form is secure and encrypted. More information about secure forms and your privacy here.
|




